Elawyers Elawyers
Washington| Change

Case v. Azar, 1:17CV741. (2019)

Court: District Court, E.D. North Carolina Number: infdco20190416d44 Visitors: 10
Filed: Apr. 15, 2019
Latest Update: Apr. 15, 2019
Summary: ORDER THOMAS D. SCHROEDER , District Judge . On January 3, 2019, in accordance with 28 U.S.C. 636(b), the Recommendation of the United States Magistrate Judge was filed and served on the parties in this action, and a copy was given to the court. Within the time limitation set forth in the statute, counsel for Plaintiff objected to the Recommendation. (Doc. 25.) Plaintiff contends that her off-label use of the drug Myfortic should be covered under Medicare Part D, the Medicare prescriptio
More

ORDER

On January 3, 2019, in accordance with 28 U.S.C. § 636(b), the Recommendation of the United States Magistrate Judge was filed and served on the parties in this action, and a copy was given to the court. Within the time limitation set forth in the statute, counsel for Plaintiff objected to the Recommendation. (Doc. 25.) Plaintiff contends that her off-label use of the drug Myfortic should be covered under Medicare Part D, the Medicare prescription drug benefit of the Medicare program, 42 U.S.C. § 1395w-101 et seq.

The court has made a de novo determination of the portions of the Recommendation to which objections were made, which is in accord with the Magistrate Judge's Recommendation. The court therefore adopts the Recommendation.

IT IS THEREFORE ORDERED that Plaintiff's motion for summary judgment (Doc. 16) is DENIED, that Defendant's motion for summary judgment (Doc. 18) is GRANTED, that the final agency decision of the Secretary is upheld, and that this action is DISMISSED WITH PREJUDICE.

A Judgment dismissing this action will be entered contemporaneously with this Order.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer